# OnCo record paper-lace-adjuvant-cisplatin-pooled-analysis-jco-2008 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-lace-adjuvant-cisplatin-pooled-analysis-jco-2008/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-lace-adjuvant-cisplatin-pooled-analysis-jco-2008" ;
  schema:name "Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group"@en ;
  schema:description "Pooling 4,584 patients from the five big trials of chemotherapy after lung cancer surgery gave a clear answer: it helps, by about 5 percent at five years, and the benefit is in stage II and III rather than stage IA."@en ;
  schema:url <https://onco.cc/key-papers/paper-lace-adjuvant-cisplatin-pooled-analysis-jco-2008/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2007.13.9030>, <https://pubmed.ncbi.nlm.nih.gov/18506026/> ;
  onco:tag "lung-evidence" ;
  schema:sameAs <https://doi.org/10.1200/JCO.2007.13.9030> ;
  schema:datePublished "2008"^^xsd:gYear ;
  schema:author "Pignon JP, Tribodet H, Scagliotti GV, et al." ;
  onco:related <https://onco.cc/key-papers/paper-nsclc-collaborative-group-chemotherapy-meta-analysis-bmj-1995/>, <https://onco.cc/key-papers/paper-adaura-nejm-2020/>, <https://onco.cc/key-papers/paper-wu-alina-adjuvant-alectinib-nejm-2024/>, <https://onco.cc/key-papers/paper-felip-impower010-adjuvant-atezolizumab-lancet-2021/> ;
  onco:cancers <https://onco.cc/cancers/lung-cancer/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/resectable-nsclc/> ;
  onco:sections <https://onco.cc/fronts/surgery/> ;
  onco:technologies <https://onco.cc/terms/radiotherapy/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/vinorelbine/>, <https://onco.cc/drugs/etoposide/> ;
  onco:terms <https://onco.cc/terms/neoadjuvant-adjuvant/>, <https://onco.cc/terms/performance-status/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-trial-design/>, <https://onco.cc/bottlenecks/b-dormancy-mrd/> ;
  onco:journals <https://onco.cc/journals/jco/> .